Creso Pharma
(ASX:CPH) is set to release CBD-based pills and supplements for sports pain relief across Europe.
They are addressing the need for organic and efficient support for the management of pain - related to sports injuries and age-related symptoms such as stiffness from arthritis.
They have partnered with the largest independent Swiss manufacturing group called FRIKE technologies to produce the CBD-based range.
The company will introduce the cannaDOL product across Europe to alleviate joint and muscle pain.
Shares in Creso Pharma
(ASX:CPH) are currently trading around 2.96 per cent higher to $0.87.
